Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Abdominal aortic aneurysm
(
AAA
) is characterized by dilatation of arterial walls, which is accompanied by degradation of elastin and collagen molecules. Biochemical and environmental factors are known to be relevant for
AAA
development, and familial predisposition is well recognized. A connective tissue disorder that is also associated with fragmentation of elastic fibers is Pseudoxanthoma elasticum (PXE). PXE is caused by mutations in the
ABCC6
gene and mainly affects dermal, ocular and all vascular tissues. To investigate whether variations in
ABCC6
are found in
AAA
patients and to determine mutations in PXE patients, we analyzed seven selected
ABCC6
exons of 133
AAA
and 54 PXE patients subjected to mutational analysis. In our cohort of
AAA
patients, we found five
ABCC6
alterations, which result in missense or silent amino acid variants. The allelic frequencies of these sequence variations were not significantly different between
AAA
patients and healthy controls. Therefore, we suggest that alterations in
ABCC6
are not a genetic risk factor for
AAA
. Mutational screening of the PXE patients revealed 19 different
ABCC6
variations, including two novel PXE-causing mutations. These results expand the
ABCC6
mutation database in PXE.
...
PMID:Analysis of sequence variations in the ABCC6 gene among patients with abdominal aortic aneurysm and pseudoxanthoma elasticum. 1612 78